Carney Complex

[1]  N. Shah,et al.  Primary pigmented nodular adrenocortical disease (PPNAD): single centre experience , 2019, Journal of pediatric endocrinology & metabolism : JPEM.

[2]  C. Stratakis,et al.  Carney complex: an update. , 2015, European journal of endocrinology.

[3]  S. Asa,et al.  Carney complex with adrenal cortical carcinoma. , 2012, The Journal of clinical endocrinology and metabolism.

[4]  J. Bertherat,et al.  Mutations in regulatory subunit type 1A of cyclic adenosine 5'-monophosphate-dependent protein kinase (PRKAR1A): phenotype analysis in 353 patients and 80 different genotypes. , 2009, The Journal of clinical endocrinology and metabolism.

[5]  C. Stratakis,et al.  Carney complex: the first 20 years , 2007, Current opinion in oncology.

[6]  J. Bertherat.  Carney complex (CNC) , 2006, Orphanet journal of rare diseases.

[7]  C. Stratakis,et al.  Clinical and molecular features of the Carney complex: diagnostic criteria and recommendations for patient evaluation. , 2001, The Journal of clinical endocrinology and metabolism.

[8]  C. Stratakis,et al.  Genetic heterogeneity and spectrum of mutations of the PRKAR1A gene in patients with the carney complex. , 2000, Human molecular genetics.

[9]  J. Carney,et al.  Carney complex: diagnosis and management of the complex of spotty skin pigmentation, myxomas, endocrine overactivity, and schwannomas. , 1998, American journal of medical genetics.

[10]  P. Carpenter,et al.  The Complex of Myxomas, Spotty Pigmentation, and Endocrine Overactivity , 1985, Medicine.

[11]  W. Young,et al.  Primary pigmented nodular adrenocortical disease and its associated conditions , 1992 .